摘要
目的:研究降纤酶对急性脑梗死患者血液流变学、血凝学及D二聚体的影响,以及对脑梗死治疗的作用机制。方法:抽取急性脑梗死患者的静脉血,测定用降纤酶治疗前后的血液流变学、血凝学与D二聚体的变化。结果:降纤酶治疗前后血液流变学5项指标、血凝学2项指标CT和PPT、D二聚体比较差异均有统计学意义;降纤酶组与常规治疗组的全血粘度、D二聚体差异有统计学意义,P<0.05,血浆粘度、纤维蛋白原比较差异有统计学意义,P<0.001,血凝学3项指标差异无统计学意义,P>0.05。结论:降纤酶可降低急性脑梗死患者的血粘度,尤其是纤维蛋白原、HCT,并使D二聚体升高,但不增加出血倾向,是治疗急性脑梗死的有效药物。
Objective:To investigate the changes of hemorheol ogy,hemoaggltination a nd D-dimer in patients with acute cerebral infarction treated with defibra se and the mechanism of defibrase in the treatment of acute cerebral infarcti on.Methods:The changes of hemorheology ,hemoaggltinat ion and D-dimer were determined before and after treatment with defibrase in 86 cases of acute cerebral infarction.Results:(1) In defibrase groups, th ere change were significant in hemorheology ,hemoagg ltination and D-dimer. (2) Compared with contrast group,there were significant differences,in the changes of h emorheology and D-dimer ,but no statistical differences in three indexes of hemoaggltination.Concl usion:Defibrase can dec rease blood viscos ity ,especially fibrinogen and HCT,in acute cerebral infarction,and it can al so increase D-dimer,but does not show hemorrhagic tendency,therefore defib rase was an effective drug in the treatment of acute cerebral infarction.
出处
《山东医科大学学报》
2002年第1期77-78,共2页
Acta Academiae Medicinae Shandong